Related Experiment Video
Updated: May 26, 2026

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor
Published on: August 18, 2023
Developing assays to address identity, potency, purity and safety: cell characterization in cell therapy process
Jessica Carmen1, Scott R Burger, Michael McCaman
1Therapeutic Cell Solutions Research & Development, Lonza Bioscience, 8830 Biggs Ford Road, Walkersville, MD 21793, USA.
Developing scalable cell manufacturing requires understanding cell characteristics to maintain critical quality attributes. Thorough cell characterization ensures biological functions remain intact for successful cell therapy commercialization.
Area of Science:
- Biotechnology
- Cell Therapy Manufacturing
- Process Development
Background:
- Commercializing cell-based therapies faces challenges in scalable manufacturing.
- Maintaining critical quality parameters (identity, potency, purity, safety) is crucial for live cell products.
Purpose of the Study:
- To discuss the importance of cell characterization in process development for cell-based therapies.
- To highlight how understanding cell properties aids in streamlining manufacturing and clinical advancement.
Main Methods:
- Review of process development activities like extended passaging and serum reduction.
- Emphasis on cell characterization as a key tool.
Main Results:
- Process development strategies must ensure biological functions remain intact.
- Cell characterization provides a thorough understanding of cell-based products.
Conclusions:
- Cell characterization is essential for successful process development in cell therapy.
- Effective characterization facilitates the progression of cell therapy products through clinical development to commercialization.
More Related Videos
08:46A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
09:19High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
Published on: January 4, 2015